No Picture
News

Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024

MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced […]

No Picture
News

Semiconductor Research Corporation Announces 2024 Call for Research, $13.8M in Funding Opportunities

DURHAM, N.C.–(BUSINESS WIRE)– #connectinginnovators–Semiconductor Research Corporation (SRC), a premier research and workforce development consortium, is announcing the start of solicitation season with $13.8 million in funding opportunities. Calls for research will begin in early April […]

No Picture
News

Nodexus Adds Flow Cytometry Leaders to Scientific Advisory Board

SAN JOSE, Calif.–(BUSINESS WIRE)– #affordable–Nodexus Inc., a leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory […]

No Picture
News

MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions

SAN FRANCISCO & ZUG, Switzerland–(BUSINESS WIRE)–MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, and Komodo Health today announce a new technology partnership to help improve treatment […]